title: Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment.
authors.forename: Marielle J
authors.initials: MJ
authors.lastname: Wondergem
authors.forename: Katrien
authors.initials: K
authors.lastname: Grünberg
authors.forename: Bart P H
authors.initials: BP
authors.lastname: Wittgen
authors.forename: Pieter
authors.initials: P
authors.lastname: Sonneveld
authors.forename: Sonja
authors.initials: S
authors.lastname: Zweegman
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000150:complications*; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000473:pathology; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib